Europe Enzymatic DNA Synthesis Market

The Europe enzymatic DNA synthesis market is expected to grow from US$ 78.55 million in 2022 to US$ 727.79 million by 2028. It is estimated to record a CAGR of 44.9% from 2022 to 2028.   

Surging Number of Product Launches Fuels

Europe Enzymatic DNA Synthesis Market Growth

Advancements in medical technologies and an increase in investments in R&D by manufacturers have resulted in the launch of various modern systems for genetic and molecular biology studies. Companies in the Europe enzymatic DNA synthesis market are involved in different product development activities. In November 2021, OriCiro Genomics Inc. launched the OriCiro Cell-Free Switching system. In June 2021, DNA Script commercially launched its SYNTAX platform with the first product—the SYNTAX System. This system is the first benchtop nucleic acid printer powered by enzymatic DNA synthesis (EDS) technology. The SYNTAX System is a fully integrated, automated printer that synthesizes 96 DNA oligos in parallel, each of length of up to 60 nucleotides, and delivers them ready for use in molecular biology and genomics workflows, eliminating the need for additional handling. In January 2021, Codex DNA, Inc. signed a strategic collaboration and licensing agreement with Pfizer to access and further develop the novel EDS technology of Codex DNA for its potential application in Pfizer’s mRNA-based vaccines and other biopharma products.

Such developments help end users meet the rising demand for technically advanced systems that can efficiently manage data and provide accurate results, thereby boosting the Europe enzymatic DNA synthesis market growth.

Europe Enzymatic DNA Synthesis Market Overview

The Europe enzymatic DNA synthesis market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the enzymatic DNA synthesis market. The market is expected to witness significant growth during the forecast period due to factors such as the growing prevalence of genetic diseases and the favorable initiatives to detect diseases in the region.

Europe Enzymatic DNA Synthesis Market Revenue and Forecast to 2028 (US$ Million)

Europe Enzymatic DNA Synthesis Strategic Insights

Strategic insights for the Europe Enzymatic DNA Synthesis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Enzymatic DNA Synthesis Report Scope

Europe Enzymatic DNA Synthesis Regional Insights

The geographic scope of the Europe Enzymatic DNA Synthesis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Enzymatic DNA Synthesis Market Segmentation

The Europe enzymatic DNA synthesis market is segmented into product type, application, technology, end user, and country.

Based on product type, the Europe enzymatic DNA synthesis market is segmented into custom DNA synthesis and DNA library synthesis. The DNA library synthesis segment held  a larger share of the Europe enzymatic DNA synthesis market in 2022.

Based on application, the Europe enzymatic DNA synthesis market is segmented into synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and others. The synthetic biology segment held the largest share of the Europe enzymatic DNA synthesis market in 2022.

Based on technology, the Europe enzymatic DNA synthesis market is segmented into SOLA, CRISPR, PCR, and others. The PCR segment held the largest share of the Europe enzymatic DNA synthesis market in 2022.

Based on end user, the Europe enzymatic DNA synthesis market is segmented into academic & research institutes, biotech & pharmaceutical companies, diagnostic laboratories, and others. The biotech and pharmaceutical companies segment held the largest share of the Europe enzymatic DNA synthesis market in 2022

Based on country, the Europe enzymatic DNA synthesis market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Germany dominated the share of the Europe enzymatic DNA synthesis market in 2022.   

Camena Bio; DNA Script; Evonetix; GenScript Biotech Corporation; Synbio Technologies; Telesis Bio Inc; Touchlight; and Twist Bioscience are the leading companies operating in the Europe enzymatic DNA synthesis market.